No Public Ratings Yet

Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for patients with serious diseases. They prioritize patients, drive scientific innovation, and promote health equity while maintaining integrity and sustainability in their operations.

SOCIALS

Updated 2 weeks ago

How woke is Bristol-Myers Squibb?

Full review coming soon! Meanwhile, check out the links below that influenced our score:

0 0 votes
Rate this brand
0 Comments
Inline Feedbacks
View all comments

Our rating is based

on these article and sources.

Does Bristol-Myers Squibb have woke marketing?

CNBC

Karuna Therapeutics surges 47% after Bristol Myers Squibb...

Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna's stock closed up more than 47% on the news Friday, hitting $317.85 a share. Bristol Myers Squibb shares closed up 2%.

Advertisement

0
Would love your thoughts, please comment.x
()
x